rubidium has been researched along with Triple Negative Breast Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cobos, SN; Contel, M; Hubbard, K; Nayeem, N; Yeasmin, A; Younes, A | 1 |
1 other study(ies) available for rubidium and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)-Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells.
Topics: Antineoplastic Agents; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Coordination Complexes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Imines; Molecular Structure; Phosphoranes; Rubidium; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2021 |